Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Vaccine

• Publication date

  2011-10-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2011.07.058PMID 21798299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

  2010cited by this paper
• Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection.

  2010cited by this paper
• Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination.

  2010cited by this paper
• NS4A regulates the ATPase activity of the NS3 helicase: a novel cofactor role of the non-structural protein NS4A from West Nile virus.

  2009cited by this paper
• RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters.

  2009cited by this paper
• Ixiaro®: a new vaccine against Japanese encephalitis

  2009cited by this paper
• Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology

  2009cited by this paper
• Evaluation of interferences between dengue vaccine serotypes in a monkey model.

  2009cited by this paper
• Virus-Specific Cytolytic Antibodies to Nonstructural Protein 1 of Japanese Encephalitis Virus Effect Reduction of Virus Output from Infected Cells

  2009cited by this paper
• The role of RNAi and microRNAs in animal virus replication and antiviral immunity.

  2009cited by this paper
• Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus

  2008cited by this paper
• Acute disseminated encephalomyelitis

  2008cited by this paper
• Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2

  2008cited by this paper
• Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system.

  2008cited by this paper
• Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.

  2008cited by this paper
• Early Production of Type I Interferon during West Nile Virus Infection: Role for Lymphoid Tissues in IRF3-Independent Interferon Production

  2007cited by this paper
• West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR

  2007cited by this paper
• WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.

  2007cited by this paper
• Flaviviridae :T he Viruses and Their Replication

  2007cited by this paper
• Vaccines for preventing Japanese encephalitis.

  2007cited by this paper
• Japanese encephalitis for a reference to international travelers.

  2007cited by this paper
• Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All

  2006cited by this paper
• Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc γ Receptor-Dependent and -Independent Mechanisms

  2006cited by this paper
• Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence.

  2006cited by this paper
• Production and characterization of vaccines based on flaviviruses defective in replication.

  2006cited by this paper
• Japanese encephalitis vaccines.

  2006cited by this paper
• A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.

  2005cited by this paper
• Mimicking live flavivirus immunization with a noninfectious RNA vaccine

  2004cited by this paper
• ChimeriVax-West Nile Virus Live-Attenuated Vaccine: Preclinical Evaluation of Safety, Immunogenicity, and Efficacy

  2004cited by this paper
• Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells.

  2004cited by this paper
• Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

  2004cited by this paper
• Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.

  2003cited by this paper
• Stable High-Producer Cell Clone Expressing Virus-Like Particles of the Japanese Encephalitis Virus E Protein for a Second-Generation Subunit Vaccine

  2003cited by this paper
• Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

  2003cited by this paper
• Partial protective effect of inactivated Japanese encephalitis vaccine on lethal West Nile virus infection in mice.

  2003cited by this paper
• Immunization with Heterologous Flaviviruses Protective Against Fatal West Nile Encephalitis

  2002cited by this paper
• Generation and Characterization of a Mammalian Cell Line Continuously Expressing Japanese Encephalitis Virus Subviral Particles

  2001cited by this paper
• A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.

  2001cited by this paper
• Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

  2001cited by this paper
• Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine

  2000cited by this paper
• Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman Primates

  2000cited by this paper
• Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

  2000cited by this paper
• Genetic Interaction of Flavivirus Nonstructural Proteins NS1 and NS4A as a Determinant of Replicase Function

  1999cited by this paper
• Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties

  1999cited by this paper
• Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1.

  1999cited by this paper
• DNA Immunization with Japanese Encephalitis Virus Nonstructural Protein NS1 Elicits Protective Immunity in Mice

  1998cited by this paper
• Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A.

  1998cited by this paper
• Proteolytic activation of tick-borne encephalitis virus by furin

  1997cited by this paper
• trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication

  1997cited by this paper
• An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995

  1996cited by this paper
• Evidence that flavivirus NS1-NS2A cleavage is mediated by a membrane-bound host protease in the endoplasmic reticulum

  1995cited by this paper
• Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.

  1992cited by this paper
• Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.

  1992cited by this paper
• Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection.

  1992cited by this paper
• Two-way cross-protection between West Nile and Japanese encephalitis viruses in bonnet macaques.

  1992cited by this paper
• A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine.

  1992cited by this paper
• Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.

  1991cited by this paper
• Passive protection studies in mice with monoclonal antibodies directed against the non-structural protein NS3 of dengue 1 virus.

  1990cited by this paper
• A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

  1988cited by this paper
• Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.

  1988cited by this paper
• Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.

  1988cited by this paper
• Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1

  1986cited by this paper
• Epitope mapping of flavivirus glycoproteins.

  1986cited by this paper

• Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection

  2024cites this paper
• Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice

  2023cites this paper
• Evaluation of codon usage patterns and molecular evolution dynamics in Japanese encephalitis virus: An integrated bioinformatics approach.

  2023cites this paper
• Flavivirus NS1 and Its Potential in Vaccine Development

  2021cites this paper
• Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice.

  2020cites this paper
• Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and May Elicit NS1-Specific Antibody Responses in Vaccinated Individuals

  2020cites this paper
• Optimized Expression of Duck Tembusu Virus E Gene Delivered by a Vectored Duck Enteritis Virus In Vitro

  2019cites this paper
• Recent developments in vaccines and biological therapies against Japanese encephalitis virus

  2018cites this paper
• Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions

  2018cites this paper
• The immune response against flaviviruses

  2018cites this paper
• Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein

  2018cites this paper
• Flavivirus NS1: a multifaceted enigmatic viral protein

  2016cites this paper
• Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable of expressing a foreign gene.

  2015cites this paper
• The present and future of veterinary vaccines for Japanese encephalitis in Korea

  2015cites this paper
• Japanese Encephalitis: An overview of vaccine development

  2014cites this paper
• Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus

  2014cites this paper
• Japanese Encephalitis Virus: The Complex Biology of an Emerging Pathogen

  2013cites this paper
• Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice.

  2012cites this paper
• Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model

  2012cites this paper
• Induction of antigen-specific immune responses in mice by recombinant baculovirus expressing premembrane and envelope proteins of West Nile virus

  2012cites this paper
• Research advances in plant-made flavivirus antigens.

  2012cites this paper